Cytokine production by activated plasmacytoid dendritic cells and natural killer cells is suppressed by an IRAK4 inhibitor
Abstract Background In systemic lupus erythematosus (SLE), immune complexes (ICs) containing self-derived nucleic acids trigger the synthesis of proinflammatory cytokines by immune cells. We asked how an interleukin (IL)-1 receptor-associated kinase 4 small molecule inhibitor (IRAK4i) affects RNA-IC...
Main Authors: | Karin Hjorton, Niklas Hagberg, Elisabeth Israelsson, Lisa Jinton, Olof Berggren, Johanna K. Sandling, Kristofer Thörn, John Mo, The DISSECT consortium, Maija-Leena Eloranta, Lars Rönnblom |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-10-01
|
Series: | Arthritis Research & Therapy |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13075-018-1702-0 |
Similar Items
-
The regulation and pharmacological modulation of immune complex induced type III IFN production by plasmacytoid dendritic cells
by: Karin Hjorton, et al.
Published: (2020-06-01) -
Early onset monocular hydroxychloroquine maculopathy in a systemic lupus erythematosus patient with history of central retinal artery occlusion: a case report
by: Ahmed Ameen Ismail, et al.
Published: (2022-11-01) -
Plasmacytoid dendritic cells and RNA-containing immune complexes drive expansion of peripheral B cell subsets with an SLE-like phenotype.
by: Olof Berggren, et al.
Published: (2017-01-01) -
TLR7 Protein Expression in Mild and Severe Lupus-Prone Models Is Regulated in a Leukocyte, Genetic, and IRAK4 Dependent Manner
by: Teja Celhar, et al.
Published: (2019-07-01) -
Androgen-Mediated Anti-inflammatory Cellular Processes as Therapeutic Targets in Lupus
by: Jessica M. Jones, et al.
Published: (2020-06-01)